1. A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastases
   Eric Marks et al, 2015, Cancer Biology & Therapy CrossRef
2. Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer
   Sander Ketzer et al, 2018, Clinical Pharmacokinetics CrossRef
3. Rechallenge chemotherapy as a third line treatment option for metastatic colorectal carcinoma
   Ersin Özaslan et al, 2017, Ortadoğu Tıp Dergisi CrossRef
4. Delineating the functional map of the interaction between nimotuzumab and the epidermal growth factor receptor
   Yaima Tundidor et al, 2014, mAbs CrossRef
5. Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial
   Maria Carmela Piccirillo et al, 2020, Clinical Colorectal Cancer CrossRef
6. Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action
   Christina Kline et al, 2013, Pharmaceuticals CrossRef
7. Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies
   Gianluca Mauri et al, 2019, Cancer Treatment Reviews CrossRef
8. A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/− targeted therapy
   Dorte Lisbet Nielsen et al, 2014, Cancer Treatment Reviews CrossRef